In July of this year, the new Scientific Director, Prof Josef Penninger, took office at the Helmholtz Centre for Infection Research (HZI). He succeeds Prof Dirk Heinz, who stepped down from his position after 13 years...
The Federal Ministry of Education and Research (BMBF) is funding the establishment of a German-Ukrainian core of excellence to help discover new anti-infectives and make them available for medical purposes. The core of...
The Alliance of Science Organisations in Germany expresses its deepest condolences for the victims of the terrorist attacks on Israel. In particular, our sympathy is with our friends and colleagues in the Israeli...
Mecklenburg-Western Pomerania's Minister of Science, Bettina Martin, announced today (July 31, 2023) in Greifswald 15 million euros of additional state funding for the construction of the Helmholtz Institute for One...
Pharma-backed incubator INCATE selected the HZI start-up project Myxobiotics as one of the first start-ups to get support. Myxobiotics develops a new class of antibiotics against Acinetobacter baumannii, which causes...
The Minister President of Lower Saxony, Stephan Weil, visited the Helmholtz Centre for Infection Research (HZI) today, 4 February 2022. The visit focused on the current challenges and innovative approaches, especially...
Principal Investigator Mathias Munschauer aims to better understand SARS-CoV-2. He now receives funding of 1.5 million euros for his research project “COVIDecode” from the European Research Council (ERC). Munschauer is...
Many active substances used in medicine are based on naturally occurring products. However, the producers of these substances often do not grow or grow poorly under laboratory conditions. This also applies to marine...
Antibiotics affect the composition and dynamics of the gut microbiome. Treatment with antibiotics not only leads to a loss of biodiversity of microorganisms, but also often favours the selection of resistant strains of...